Back to search results

Stomach Cancer, Gastroesophageal Junction Cancer (GEJ)

A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer

JVCZ | {{ defaultRegistry.registryAnchorText }} NCT02514551 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The main purpose of this study is to evaluate the efficacy of an alternative dose of ramucirumab in combination with paclitaxel in participants with second-line metastatic or locally advanced, unresectable gastric or gastroesophageal junction adenocarcinoma (GEJ).

Completed Study

The results of this study are not yet available.

Time Commitment

You can participate in this study for as long as your study doctor determines that you are benefiting from the study treatment.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


18+ years
  • Participant must have a diagnosis of Gastric Cancer (gastric or gastroesophageal junction adenocarcinoma (GEJ) adenocarcinoma)

  • Participant must have disease progression during or within 4 months after last dose of first-line chemotherapy

  • Participant must have received combination chemotherapy

  • Male participants must be sterile or agree to use a reliable method of birth control

  • Female participants of child-bearing potential must have a negative pregnancy test and agree to use a highly effective method of birth control; all other female participants must be surgically sterile or postmenopausal

  • Participant must not have known brain metastases or leptomeningeal disease

  • Participant must not have a history of gastrointestinal perforation or fistula within 6 months

  • Participant must not have a history of inflammatory bowel disease or Crohn's disease requiring medical intervention within 12 months

  • Participant must not have Child-pugh B, C cirrhosis or HIV

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.